Use App
AI Agent
Trending
News
Earnings
All
DIA
0.87%
SPY
0.60%
QQQ
0.49%
Trending
SHIB
1.84%
T.TSX
3.50%
XLF
0.92%
TMUS
13.27%
C
1.22%
SQD
0.19%
NEM
1.98%
ELF
3.09%
EBS
3.67%
TOSHI
2.57%
Feed
News
Sentiment
Fundamentals
Info
home
Symbol
GRI
news
Exchange:
NASDAQ
·
Updated 07:30 PM EDT
GRI News
News
all
press releases
GRI Bio, Inc. (GRI) Upgraded to Buy: What Does It Mean for the Stock?
GRI Bio, Inc. (GRI) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
Zacks
GRI Bio Reports Positive Study Results For Chronic Lung Disease, But Stock Slumps 20% — What Happened?
The company said that the new data indicate that GRI-0621 may support the regeneration of lung tissue.
Stocktwits
Full Article
GRI Bio Drug Shows Promising Lung Function Recovery In Patients With Thickened Lungs
GRI Bio shared promising data from a Phase 2a trial for idiopathic pulmonary fibrosis, a chronic lung disease with no known cause.read more...
Benzinga
Barclays lifts Kojamo, I-RES ratings; cuts Grainger on low yield
investing.com
1
Advertisement
|
Remove ads.
Home
Watchlist
Trending
News
Explore
Profile